Biliary tract cancer
Juan W. Valle, Robin Kate Kelley, Bruno Nervi et al. · The Lancet · 2021
Cited by 1,043 works. doi:10.1016/s0140-6736(21)00153-7
Authors
References
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- AJCC Cancer Staging Manual
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States